Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Renata O. Smith"'
Autor:
Sarah M Michienzi, Mikayla Johnson, Thomas D Chiampas, Eric Wenzler, Rodrigo M Burgos, Renata O Smith, Melissa E Badowski
Publikováno v:
Drugs in Context, Vol 10, Pp 1-6 (2021)
Although tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) have been evaluated in various clinical trials, limited safety and efficacy data exist in real-world settings. The goal of this retrospective analysis is to assess changes i
Externí odkaz:
https://doaj.org/article/59c8178f2e7c4937891fdf0c3583f0cc
Autor:
Rodrigo M Burgos, Melissa E Badowski, Emily Drwiega, Samaneh Ghassemi, Nikki Griffith, Fischer Herald, Mikayla Johnson, Renata O Smith, Sarah M Michienzi
Publikováno v:
Drugs in Context, Vol 10, Pp 1-10 (2021)
The unprecedented toll of severe acute respiratory syndrome coronavirus 2, the virus responsible for coronavirus 2019 disease (COVID-19), jumpstarted the race towards the development and distribution of effective treatment and prevention options. Wit
Externí odkaz:
https://doaj.org/article/aaf3485259f94dc3a9983308cc40f128
Publikováno v:
J Pediatr Pharmacol Ther
Single tablet regimens (STRs) have simplified antiretroviral therapy (ART) over the years in the adult human immunodeficiency virus (HIV) population. However, there is still a prevalent need to simplify regimens in children and adolescents living wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a55d22e4a5b51debc31498e8043d3e6
https://doi.org/10.5863/1551-6776-26.8.783
https://doi.org/10.5863/1551-6776-26.8.783
Autor:
Rodrigo M Burgos, Eric Wenzler, Mikayla Johnson, Renata O. Smith, Thomas D Chiampas, Melissa E Badowski, Sarah M Michienzi
Publikováno v:
Drugs in Context, Vol 10, Pp 1-6 (2021)
Drugs in Context
Drugs in Context
Although tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) have been evaluated in various clinical trials, limited safety and efficacy data exist in real-world settings. The goal of this retrospective analysis is to assess changes i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50b51a02ae4a93b01030263107ae75c0
https://doi.org/10.7573/dic.2021-2-1
https://doi.org/10.7573/dic.2021-2-1
Autor:
Nicholas S. Britt, Misty M. Miller, Renata O. Smith, Elizabeth M Sherman, Emily Huesgen, Kathleen Nowak, Michelle M. Lewis, Melissa E Badowski
Publikováno v:
Pharmacotherapy
Pharmacotherapy considerations are often a concern for transgender individuals who are living with human immunodeficiency virus (HIV) due to concerns for drug-drug interactions between their hormone and antiretroviral therapies. Many of the first-lin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::920d74ec3dbdcbcc15964a5649054978
https://doi.org/10.1002/phar.2499
https://doi.org/10.1002/phar.2499
Autor:
Nikki Griffith, Sarah M Michienzi, Samaneh Ghassemi, Mikayla Johnson, Melissa E Badowski, Renata O. Smith, Rodrigo M Burgos, Fischer Herald, Emily N. Drwiega
Publikováno v:
Drugs in Context, Vol 10, Pp 1-10 (2021)
Drugs in Context
Drugs in Context
The unprecedented toll of severe acute respiratory syndrome coronavirus 2, the virus responsible for coronavirus 2019 disease (COVID-19), jumpstarted the race towards the development and distribution of effective treatment and prevention options. Wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2abfba94e722406e1f47585776c16302
https://www.drugsincontext.com/the-race-to-a-covid-19-vaccine:-opportunities-and-challenges-in-development-and-distribution
https://www.drugsincontext.com/the-race-to-a-covid-19-vaccine:-opportunities-and-challenges-in-development-and-distribution
Autor:
Melissa E Badowski, Renata O. Smith, Rodrigo M Burgos, Thomas D Chiampas, Paa Kwesi Yanful, Marisa B Brizzi, Sarah M Michienzi
Publikováno v:
Open Forum Infectious Diseases
Background Persons with human immunodeficiency virus (HIV) experience high rates of medication-related errors when admitted to the inpatient setting. Data are lacking on the impact of a combined antiretroviral (ARV) stewardship and transitions of car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04cd5f90bde92fa64d2b2ff96d8590d7
https://doi.org/10.1093/ofid/ofaa073
https://doi.org/10.1093/ofid/ofaa073
Autor:
Rodrigo M Burgos, Renata O. Smith, Melissa E. Badowski, Marisa B Brizzi, Thomas D Chiampas, Sarah M Michienzi
Publikováno v:
PharmacotherapyFirst: A Multimedia Learning Resource
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8bc0e7ad56ca492c4b2afa43fdd2327
https://doi.org/10.21019/pharmacotherapyfirst.immunocompromised_facultymaterials
https://doi.org/10.21019/pharmacotherapyfirst.immunocompromised_facultymaterials
Autor:
Rodrigo M Burgos, Renata O. Smith, Thomas D Chiampas, Sarah M Michienzi, Marisa B Brizzi, Melissa E. Badowski
Publikováno v:
PharmacotherapyFirst: A Multimedia Learning Resource
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9feabd6f688042e9c7a275678f179fd
https://doi.org/10.21019/pharmacotherapyfirst.immunocompromised_casebasedlearning
https://doi.org/10.21019/pharmacotherapyfirst.immunocompromised_casebasedlearning
Autor:
Sarah M. Michienzi, Melissa E. Badowski, Rodrigo M. Burgos, Thomas D. Chiampas, Renata O. Smith, Marisa Brizzi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db98c16236e31ec16c541e7beb0fc58a
https://doi.org/10.21019/pharmacotherapyfirst.immunocompromised_overview
https://doi.org/10.21019/pharmacotherapyfirst.immunocompromised_overview